NCT03131713

Brief Summary

The study's goal is to assess impact of preoperative acetaminophen and oral carbohydrate drinks on pain and functional status experienced by patients undergoing Mohs micrographic surgery for non-melanoma skin cancers. Patients are randomly assigned to receive standard of care or preoperative acetaminophen 1000 mg and Gatorade sports drinks 2 packets before surgery. Patients are then asked to rate their level of pain, anxiety, thirst, hunger, fatigue on a scale of 0-100 on day of surgery before surgery has started, after clearance of skin cancer, and at the end of the visit. Patients are contacted by phone 48 hours after their surgery to assess their maximum level of post-operative pain (rated from 0-100), usage of over the counter or prescribed pain medications, and presence of complications e.g. bleeding, infection, dehiscence. Differences in perioperative functional status and pain medication usage are compared between patients in control and intervention groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Jul 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2016

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

March 6, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 27, 2017

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2017

Completed
1.8 years until next milestone

Results Posted

Study results publicly available

October 7, 2019

Completed
Last Updated

October 7, 2019

Status Verified

October 1, 2019

Enrollment Period

1.5 years

First QC Date

March 6, 2017

Results QC Date

July 12, 2019

Last Update Submit

October 4, 2019

Conditions

Keywords

Mohs micrographic surgerypainfunctional status

Outcome Measures

Primary Outcomes (1)

  • Maximum Pain Score

    Rated on a pain scale of 0-100. Higher score means worse outcome; lower score means better outcome.

    Day of surgery

Secondary Outcomes (6)

  • Thirst

    Day of surgery

  • Hunger

    Day of surgery

  • Anxiety

    Day of surgery

  • Fatigue

    Day of surgery

  • Number of Participants Using Post-operative Analgesic

    48 hours after surgery

  • +1 more secondary outcomes

Study Arms (2)

Control

NO INTERVENTION

The control group will receive usual perioperative care including patient education on diagnosis, treatment and prognosis of skin cancer, encouragement of food and fluid intake prior to and during the surgery as needed, and acetaminophen per patient request.

Intervention

EXPERIMENTAL

The intervention group, in addition to usual care, will receive Acetaminophen 1000mg and commercially available carbohydrate drink (two pouches of Gatorade Prime Sports Fuel drink containing 50gm carbohydrate in approximately 250ml fluid total) at the beginning of the surgery.

Drug: Acetaminophen

Interventions

Acetaminophen 1000mg

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients undergoing Mohs micrographic surgery for non-melanoma skin cancers (basal cell carcinoma and squamous cell carcinoma)

You may not qualify if:

  • history of liver transplant, hepatitis, or cirrhosis, those required to be NPO for subsequent closure by other surgical specialties, or those with known allergy to acetaminophen

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tufts Dermatology

Boston, Massachusetts, 02111, United States

Location

MeSH Terms

Conditions

Pain

Interventions

Acetaminophen

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Results Point of Contact

Title
Bichchau Nguyen, Principal Investigato
Organization
Tufts Medical Center

Study Officials

  • Bichchau Nguyen, M.D.

    Tufts Medical Center/Tufts University School of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 6, 2017

First Posted

April 27, 2017

Study Start

July 1, 2016

Primary Completion

December 31, 2017

Study Completion

December 31, 2017

Last Updated

October 7, 2019

Results First Posted

October 7, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will not share

Locations